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Abstract
Background: In individually randomised trials we might expect interventions delivered in groups or by care
providers to result in clustering of outcomes for participants treated in the same group or by the same care
provider. In partially nested randomised controlled trials (pnRCTs) this clustering only occurs in one trial arm,
commonly the intervention arm. It is important to measure and account for between-cluster variability in trial
design and analysis. We compare analysis approaches for pnRCTs with continuous outcomes, investigating the
impact on statistical inference of cluster sizes, coding of the non-clustered arm, intracluster correlation coefficient
(ICCs), and differential variance between intervention and control arm, and provide recommendations for analysis.
Methods: We performed a simulation study assessing the performance of six analysis approaches for a two-arm
pnRCT with a continuous outcome. These include: linear regression model; fully clustered mixed-effects model with
singleton clusters in control arm; fully clustered mixed-effects model with one large cluster in control arm; fully clustered
mixed-effects model with pseudo clusters in control arm; partially nested homoscedastic mixed effects model, and
partially nested heteroscedastic mixed effects model. We varied the cluster size, number of clusters, ICC, and individual
variance between the two trial arms.
Results: All models provided unbiased intervention effect estimates. In the partially nested mixed-effects models,
methods for classifying the non-clustered control arm had negligible impact. Failure to account for even small ICCs
resulted in inflated Type I error rates and over-coverage of confidence intervals. Fully clustered mixed effects models
provided poor control of the Type I error rates and biased ICC estimates. The heteroscedastic partially nested mixed-
effects model maintained relatively good control of Type I error rates, unbiased ICC estimation, and did not noticeably
reduce power even with homoscedastic individual variances across arms.
Conclusions: In general, we recommend the use of a heteroscedastic partially nested mixed-effects model, which models
the clustering in only one arm, for continuous outcomes similar to those generated under the scenarios of our simulations
study. However, with few clusters (3–6), small cluster sizes (5–10), and small ICC (≤0.05) this model underestimates Type I
error rates and there is no optimal model.
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Background
Randomised controlled trials (RCTs) are often categorised
into two types: individually randomised controlled trials
(iRCTs) where participants are individually randomised to
treatment arms to receive one of the investigative treat-
ments; and cluster randomised controlled trials (cRCTs)
where groups of participants (clusters) are randomised to
treatment arms. We may expect outcomes for participants
within the same cluster to be more similar than those from
different clusters. The similarity can arise due to partici-
pants in the same cluster receiving care from the same
health provider or interacting with one another [1]. The im-
plications of clustering in cRCTs are widely acknowledged
[1, 2]. Clustering results in a reduction in statistical effi-
ciency in cRCTs and if ignored standard errors and p-values
for intervention effects are typically underestimated.
Clustering can also occur in iRCTs. For instance, clus-
tering of participants outcomes due to receiving treat-
ment as part of a group-based parenting intervention
[3], treatment in specialist clinics for the treatment of
venous leg ulcers [4], or participants under the care of a
surgeon for comparison for hemostasis in elective
benign thyroid surgery [5]. The care provider or group
dynamics may play a role in the causal pathway of the
intervention effect. We might expect correlated out-
comes between individuals either in the same group or
receiving treatment from the same care provider.
Standard sample size and analysis methods for iRCTs
rely on the assumption of independence between partici-
pants, which is violated when clustering is present. The
‘clustering effect’ is commonly quantified using the
intracluster correlation coefficient (ICC). The ICC mea-
sures the extent to which outcomes from participants
within the same cluster are correlated to one another
[1]. When designing and analysing iRCTs with cluster-
ing we need to consider implications of the potential
lack of independence. Ignoring clustering in the ana-
lysis can lead to over precise results and consequently
incorrect conclusions [1]. Clustering of any form re-
sults in a reduction in the effective sample size,
hence, there is a reduction in the power to detect an
intervention effect if it truly exists.
In addition to obtaining sufficient power and accurate
results, accounting for clustering enables us to estimate
the ICC. ICCs are often important for the interpretation
of trial results; we may be directly interested in the inter-
vention group or care provider effects. ICCs are also key
when calculating sample sizes for RCTs with clustering,
in order to maintain power [1].
An increasingly applied design in healthcare and educa-
tion research is a partially nested randomised controlled
trial (pnRCT) [6], where participants are individually ran-
domised to trial arms and clustering of outcomes occurs
in only one arm of the trial [7] (also termed partially
clustered trials). The STEPWISE trial is an example of a
pnRCT, assessing a structured lifestyle education
programme aimed at supporting weight loss for adults
with schizophrenia and first episode psychosis in a
community mental health setting. Individuals were rando-
mised to either an intervention arm of group-based life-
style education sessions or a control arm receiving usual
care at the individual level [8].
Specific statistical methods need to be used for analys-
ing pnRCTs. Consequently, there has been a consider-
able growth in the methodology literature (particularly
in the fields of psychotherapy and educational research)
in the past few decades both proposing and reviewing
statistical methods for pnRCTs.
Table 1 presents a summary of relevant literature
on the analysis of pnRCTs. This expands on the lit-
erature search by Flight et al. [9] summarising models
for the analysis of pnRCTs. Sample size calculations
for pnRCTs have been addressed elsewhere [10–14].
Analysis methods for pnRCTs have mainly focussed on
using mixed-effects models, individual-level models
which account for the hierarchical structure of the data
[6, 7, 9, 15–19]. These models allow us to control for
baseline covariates and represent the different levels in the
data, including cluster, individual, and repeated measures
(where applicable). In addition to accounting for the
clustering, we may expect the variance of the individ-
ual errors to differ between trial arms in pnRCTs,
termed heteroscedastic variance [7]. When a clustered
intervention arm is compared to a non-clustered control
arm the between-cluster variation in the intervention arm
is not present in the control arm. The clustered interven-
tion may result in a decrease or increase of the individual
level variability.
In this study, we use a series of simulations to evaluate
the statistical analysis models for two-arm parallel
pnRCTs with continuous outcomes, assessing a range of
scenarios including the effect of cluster size and the
number of clusters. In theory, the mixed-effects models
can be formulated so that they do not model clustering
in the control arm, however, when running these models
in statistical software packages it is necessary to impose
some form of clustering in the control arm. The litera-
ture identified in Table 1 highlighted that research to
date is lacking in addressing the best way to treat the
non-clustered control arm when fitting the models in
statistical software, using scenarios of relevance in the
field of public health with small clusters and small ICCs
[9], and evaluating the effect of the variance ratio of the
residuals on the model fit. In pnRCTs we may have small
numbers of clusters [9], thus we evaluate the impact of
the number of clusters on statistical inference and if
statistical inference remains valid using mixed-effects
models.
Candlish et al. BMC Medical Research Methodology  (2018) 18:105 Page 2 of 17
Table 1 Summary of relevant literature on analysis of pnRCTs
Paper Relevant themes Range of valuesa Findings
Schweig &
Pane [16]
Describe and compare models for
pnRCTs with non-compliance using
a simulation study.
Simulation for two levels of clustering,
exact cluster sizes (m) unclear in paper,
cschool = 37, cclass = 177, λB = 2, 8,
ρschool = 0.005, 0.05, 0.15, ρclass = 0.0004,
0.10, 0.25, and θ = 0.087.
Clustering and non-compliance may have
a substantial impact on statistical inference
about intention-to-treat effects. Provide
methods that may accommodate pnRCT
with non-compliance, recommend using
complier average causal effect estimate
(CACE) and scaling by the proportion of
compliers. No mention of degrees of
freedom, we have assumed they used
default degrees of freedom method
available in R lme packages.
Flight et al. [9] Compare models applied to four
examples of pnRCTs. Compare
three different methods for classifying
the non-clustered control arm in
pnRCTs, including: singleton clusters,
one large cluster and pseudo clusters.
Examples with {m, c} = {36, 8; 24, 7; 14,
8; 5, 6}, and estimated ρ = < 0.0001, 0.02,
0.007.
Recommend use of the heteroscedastic
model, recommendations based only on
re-analysis of case studies. Methods for
classifying the non-clustered control arm
in pnRCTs had a large impact in fully
clustered mixed effects models and no
measurable impact in partially nested
mixed-effects models. ICCs in four
examples were small.
Sterba [27] Review of modelling developments
for pnRCTs, focused on those particularly
relevant to psychotherapy trials.
Recommend the inclusion of cluster
variability in analysis model as it provides
insight into treatment process (rather than
treating it as a nuisance). Annotated Mplus
commands for models
Lohr, Schochet
& Sanders
[19]
Report presenting a guide to design
and analysis issues for pnRCTs in education
research, using example trials. Discussion
of degrees of freedom issue in Appendix.
Guidance document, defines pnRCT in
context of education research and show
methods to analyse these using SAS.
Provide SAS commands for model fitting
in examples.
Korendijk
[18]
Compare models for pnRCTs using
simulation study, investigate
mis-specification for the estimation
of the parameters and their standard
errors.
Simulation study with m = 5, c = 10, 30,
50, 100, ρ = 0.05, 0.1, 0.2, λA = 1, d = 0.3.
All models perform comparably with
respect to fixed effect estimates.
Recommend use of partially nested
mixed-effects model. Simulations were
under null and ICC always greater than
zero. No mention of degrees of freedom,
we have we assumed default degrees of
freedom used from MLwiN software, and
homoscedasticity was assumed for
ndividual variances between the two
arms.
Sanders [17] Compare models for pnRCTs using
simulation study in terms of Type
I error and power
Simulation study with {m, c} = {2, 10; 4,
4; 5, 4; 10, 2}, ρ = 0, 0.1, 0.2, 0.3, 0.4, 0.5,
λA = 1, and ω2 = 0, 0.01, 0.059, 0.138.
Type I error rate increased as ICC increased,
Satterthwaite degrees of freedom had
better control than Kenward-Roger degrees
of freedom. Found using mixed-effects
model for pnRCT when ICC is zero likely
leads to never detecting intervention
effects, observed Type I error rates nearly
non-existent under all scenarios with ICC
equal to zero. Recommend to evaluate if
ICC is significantly different from zero prior
to selecting analysis method. Homoscedas
ticity was assumed for individual variances
between the two arms.
Baldwin
et al. [15]
Compare analysis models for pnRCT
simulation study, comparing three
degrees of freedom calculations,
and a pnRCT example.
Simulation for m = 5, 15, 30, c = 2, 4, 8,
16, ρ = 0, 0.05, 0.1, 0.15, 0.3, λB = 0.25,
1, 4, and d = 0, 0.5.
Recommend pnRCTs take account of
heteroscedasticity. Satterthwaite and
Kenward-Roger degrees of freedom
control Type I error rate. The heteroscedas
tic model provides an unbiased estimate
and little reduction in power compared to
the homoscedastic model. Argue that using
a partially nested mixed-effects model only
a problem for statistical inference when the
number of clusters is small. The number of
clusters has greater impact on power in
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We evaluate and provide recommendations for the
most appropriate analysis methods for pnRCTs,
including:
1) where mixed-effects models are necessary,
2) methods of specifying the clusters in the non-
clustered arm when fitting a model and the impact
these have on the analysis,
3) the impact of cluster sizes and the number of
clusters on statistical inference and,
4) the impact of heteroscedastic individual variance
between trial arms on statistical inference.
Methods
Methods for analysis of partially nested trials
In this section, we present the main modelling ap-
proaches currently available and used for pnRCTs, in-
cluding ignoring clustering altogether, imposing
clustering in the non-clustered control arm, and expli-
citly modelling the partially nested design by modelling
clustering only in the intervention arm.
It is possible to account for clustering by including each
cluster as a fixed effect in a standard regression model, in
addition to a fixed effect representing the intervention ef-
fect. Although this method is simple to implement, it is
not recommended. Firstly, it does not reflect the study de-
sign of a pnRCT and may require a large number of fixed
effects to be fitted lowering the degrees of freedom [9].
Secondly, if clusters are of size one there is insufficient in-
formation to estimate both the intervention effect and the
cluster effect for each cluster. Finally, it will generally
underestimate the intervention effect variability as the
cluster level variability is removed.
Table 2 presents a summary of the models for the ana-
lysis of pnRCTs using findings from the literature search
by Flight et al. [9]. We define: y as a continuous out-
come, i is the individual participant indicator, j is the
cluster indicator, t is the intervention indicator (0 = con-
trol, 1 = intervention), θ is the intervention effect, β0 is
an intercept term. Error terms are defined depending on
the model procedure, represented using ϵ, u, and r,
where u represents the between cluster variation and ϵ
and r represent individual level variation.
Model 1 (Table 2) is the linear regression model which ig-
nores the clustering and uses analysis for non-clustered tri-
als, assuming independence between individuals regardless
of whether they are in the same cluster. This infers that the
conditional variance of y in both the intervention and con-
trol arms is equal. If the outcomes of individuals in the
same cluster are correlated, the independence assumption
Table 1 Summary of relevant literature on analysis of pnRCTs (Continued)
Paper Relevant themes Range of valuesa Findings
pnRCTs. At least eight, preferably 16 clusters,
to maintain Type I error rate.
Bauer
et al. [6]
Review of RCTs to ascertain the prevalence
of pnRCTS in four public health and clinical
research journals. Analysis models for pnRCTs
extended to include pre-test measures as
covariates, individual and group level
covariates, and example of pnRCT
Example with clustering in one arm
c = 41, m = 9, and estimated ρ = 0.02.
Out of 94 RCTs, 32% were pnRCTs, 40%
iRCTs and 27% cRCT. None used methods
specific to pnRCTs. Example pnRCT data
could be analysed using mixed-effects
models. Argue pnRCTs “often increase
external validity at the expense of internal
validity” (p.20).
Roberts &
Roberts [7]
Examine the case of pnRCTs, heterogeneity,
comparison of analysis methods for
simulation study and present an example.
Simulation for m = 6, c = 8, ρ = 0, 0.1, 0.2,
0.3, λA = 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2
and d = 0.
Recommend pnRCTs take account of
heteroscedasticity. Satterthwaite unequal
variances t-test gave robust to heterosce
dasticity. The heteroscedastic model gives
slightly inflated test size for large ρ: suggest
Satterthwaite degrees of freedom as a
solution.
Lee &
Thompson
[28]
Describe analysis models for iRCTs with
clustering and apply to two examples
(using Bayesian approach)
Show that ignoring clustering may
underestimate uncertainty, leading to
incorrect conclusions.
Hoover
[34]
Statistical tests for RCTs with clustering
that differ across trial arms.
Example with clustering in both
arms with m = 7 − 12, c = 3.
Provide an adjustment for the independent
samples t-test for pnRCTs. Statistical impact
of heterogeneity effect increases as the
cluster size increases, and as heterogeneity
increases. The test does not allow for the
inclusion of covariates, multiple treatments,
baseline measures, or non-normally
distributed outcomes.
am = cluster size, c = number of clusters, ρ= ICC, d = standardised effect size, ω2= Omega Squared effect size percent of variability accounted for by treatment
condition, λA= ratio of total variance in control arm compared to clustered, λB= ratio of individual variance in control arm compared to clustered arm. Ordered by
year of publication
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is violated and we underestimate uncertainty around inter-
vention effects when using the linear regression model
above.
Model 2 (Table 2) is the fully clustered mixed-effects
model which includes the cluster as a random effect; this
includes variability at both the individual and cluster level.
The mixed-effects model with imposed clustering of the
control arm requires the estimation of a random cluster
effect for both intervention and control groups. Some op-
tions for the imposed clustering in the control arm are
given in Table 3. The variance of the control arm and
intervention arm are assumed to be the same (homoscedas-
tic). When the variance is believed to differ between control
and intervention arm model 2 is not appropriate as it does
not account for heteroscedasticity. Models 3 and 4
(Table 2) apply the cluster effect to the clustered arm only
[7, 10, 11, 14], we term these the partially nested models.
Individuals in the non-clustered control arm are as-
sumed independent. This accurately reflects the design
of the study with clustering only in one arm. In the par-
tially nested homoscedastic model, we apply the random
effect uj to the clustered intervention arm only;
between-cluster variability is only present for the inter-
vention arm. Model 3 is homoscedastic as the variance
of the individual errors, ϵij, between arms is the same. In
practice, the variance of the individual errors may differ
between trial arms [7]. Therefore, model 3 is extended
to a partially nested heteroscedastic model, model 4,
this allows for differing individual errors between
intervention and control arms but does not constrain
the form of heteroscedasticity.
Imposed clustering in the control arm
Regardless of whether or not the model assumes cluste-
ring in one (models 3 and 4) or both arms (model 2),
within the statistical software package a decision must
be made about how to code the cluster indicators in the
control arm. One method is to impose clusters for all in-
dividuals, including those in the control arm, and use
analysis for cRCTs with clustering in both arms.
Table 3 represents the different options for imposing
clustering, j, in the control arm, l is the number of indi-
viduals in the control arm and k is the number of arbi-
trary clusters in the control group. Option one treats the
control group as one single cluster; option two treats
each individual in the control arm as their own cluster
of size one (singleton clusters) giving j=l clusters in the
control arm. ICC estimation can be problematic with
options one and two, in theory, it is not possible to
estimate between-cluster variability in option one, or es-
timate within cluster variability in the control group
using option two [20]. Option three imposes artificial
pseudo-random clusters in the control group to
overcome the problem of estimating within or between-
cluster variability. The number of arbitrary clusters, k,
needs to be considered. We chose it to be equal across
treatment arms. In addition, option three will likely
result in a lower ICC estimation due to the assumed
independence of control participants.
In our simulation study, the fully clustered model 2 is
parametrised using the imposed clustering from Table 3.
The models are:
 Model 2.1 fully clustered mixed-effects model with
singleton clusters in the control arm;
Table 2 Models for the analysis of pnRCTs
Model description Statistical model Heteroscedastic
residuals
Model 1 Linear regression
(ignore clustering)
yi = β0 + θti + ϵi
• ϵ i  Nð0; σ2ϵ Þ the individual level variation
No
Model 2 Fully clustered
(impose clustering)
yij = β0 + θtij + uj + ϵij
• u j  Nð0; σ2uÞ a random effects term representing between cluster
variation
• ϵ i j  Nð0; σ2ϵÞ the individual level variation
No
Model 3 Partially nested
homoscedastic
yij = β0 + θtij + ujtij + ϵij
• u j  Nð0; σ2uÞ a random effects term representing between-cluster variation
in clustered arm
• ϵ i j  Nð0; σ2ϵÞ the individual level variation
No
Model 4 Partially nested
heteroscedastic
yij = β0 + θtij + ujtij + rij(1 − tij) + ϵijtij
• u j  Nð0; σ2uÞ a random effects term representing between cluster-variation
in clustered arm
• rij  Nð0; σ2r Þ the individual level variation in the non-clustered control arm.
• ϵ i j  Nð0; σ2ϵÞ the individual level variation in the clustered arm
Yes
Table 3 Options for imposing clustering in the non-clustered
control arm
Option Cluster Intervention
1 j = 0 j = 1, …, c
2 j = 1, …, l j = l + 1, …, c
3 j = 1, …, k j = k + 1, …, c
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 Model 2.2 fully clustered mixed-effects model with
one large cluster in the control arm;
 Model 2.3 fully clustered mixed-effects model with
pseudo clusters in the control arm.
Flight et al. [9] investigated the effect of the different
methods of imposing clustering in the control arm
presented in Table 3 in four pnRCT case-studies. The four
case-studies covered trials evaluating the effect of: specialist
leg ulcer clinics (clustered by clinic), acupuncture for low
back pain (clustered by acupuncturist), postnatal support in
the community (clustered by community support worker),
and telephone befriending for maintaining quality of life in
older people (clustered by volunteer facilitator). Little differ-
ence was found between the different methods for the fully
clustered mixed-effects models and there was no difference
between the different methods for the partially nested
mixed-effects models.
We anticipated that the method of imposing the clus-
tering in the control arm does not affect the results of
the methods which model clustering in only one arm,
however, this evaluated in the simulation study.
Degrees of freedom for fixed effect estimates
In the mixed-effects models above we wish to carry out
significance tests for the intervention effect. In addition
to the correct choice of model, the test statistics and
degrees of freedom in mixed-effects models also need to
be considered. For large sample sizes in mixed-effects
models, the test statistics for fixed effects can be as-
sumed Normally distributed. However, for small samples,
the t-distribution is generally used as an approximation of
the distribution of the test statistic. Estimating the degrees
of freedom for the t-distribution is unclear for pnRCTs
and will affect both the significance test and the confi-
dence intervals of the intervention effect estimate.
Comparison of degrees of freedom correction methods
has been undertaken for cRCTs and pnRCTs with small
numbers of clusters [15, 21]. The Satterthwaite
small-sample degrees of freedom correction takes into
account the variance structure of the data, for pnRCTs,
it has been shown to be superior to the between-within
method for maintaining Type I error rates (and compa-
rable to the Kenward-Roger method) [15]. Following
these results, the Satterthwaite approximation was used
to calculate degrees of freedom (using dfmethod() option
for mixed, available in Stata 14 onwards [22]).
Simulation study
Overview
We performed a simulation study to evaluate the statis-
tical analysis models for pnRCTs presented in Table 2,
and the imposed clustering of the control arm in Table 3
[23]. All models were fitted using a restricted maximum
likelihood procedure (REML). All simulations were done
in Stata [22], graphs produced using ggplot2 [24] in R
[25]. See Additional file 1 for simulation code.
Data-generating mechanism
We simulated data to replicate a two-arm parallel
pnRCT trial with a non-clustered control arm and a
clustered intervention arm (randomised 1:1) and a con-
tinuous outcome. We simulated data under various de-
sign scenarios and under both the null (θ = 0) and
alternative hypothesis (θ =A, where A ≠ 0).
Data were simulated from the following model with
the intercept set to zero and group allocation denoted
by t (t = 0 for control, t = 1 for intervention arm):
 For the intervention arm ðt ¼ 1Þ yi j ¼ θ þ uj
ffiffiffi
ρ
p þ zi j
ffiffiffiffiffiffiffiffi
1−ρ
p
 For the control arm ðt ¼ 0Þ yi j ¼ zi j
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
γð1−ρÞp
Where uj~N(0, 1) and zij~N(0, 1). This simulates an ICC
of ρ and a ratio of individual level variance between the
non-clustered control arm and the clustered intervention
arm of γ. If γ = 1, there is homoscedasticity between the
individual level variance in the control and intervention
arms. Full simulation study steps, including the data
generation process and modelling, are presented in Fig. 1.
Simulation scenarios are presented in Table 4. We var-
ied: the intervention effect, ICC, cluster size, number of
clusters, and ratio of individual variance between the
trial arms. If γ = 0.25 then individual variance in the con-
trol arm is one quarter that in the intervention arm and
if γ = 4 then individual variance in the control arm is
four times that in the intervention arm.
Simulation values were chosen based on literature on
pnRCTs [7, 9, 15, 17, 18, 26–28], as well as extending
these to more extreme cases of γ and ρ that may occur
in rare instances. Reporting of ICCs in iRCTs with clus-
tering is limited at present and it is plausible that ICCs
in pnRCTs differ from those of cRCTs. Current evidence
suggests ICCs in iRCTs with clustering in either one or
both arms are generally small and often less than 0.05
[7–9, 29], hence the choice to include a small ICC ρ =
0.01 in the simulations with ICCs of 0.2 or more occur-
ring only in rare instances. We were unaware of specific
literature on the evidence of heteroscedasticity, however,
from the authors experience of working on trials it was
expected γ to typically stay within the range of 0.5–2.
The number of clusters in the intervention group was 3,
6, 12 or 24. These figures reflect the small numbers of
clusters recruited in many pnRCTs and, coupled with
the cluster sizes of 5, 10, 20 or 30, they allowed alterna-
tive combinations of cluster size and number of clusters
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to be investigated for a given total trial sample size.
Figure 2 provides a graphical example of the simulated
partially nested trial data.
Methods
Each simulated dataset was analysed using the models
described in Table 2.
Estimand
Our estimands of interest are the REML estimate of
the intervention effect θ and the model estimate of
the ICC ρ.
Performance measures
We used the following performance measures: bias,
mean square error (MSE), and coverage of 95% confi-
dence intervals for θ^, Type I error rate and power (calcu-
lated as the proportion of simulated results with a
statistically significant intervention effect at the 5% level
when the null or alternative hypothesis were true, for
Type I error and power respectively) and where appli-
cable, model estimated ICC. See Additional file 2 for
more detail on performance measures. For each of the
1440 scenarios 1000 datasets were generated; a 5%
significance level and 95% confidence interval based on
1000 simulations has a Monte Carlo error of 0.7%.
Results
Model convergence was generally satisfactory for all
models with models converging 95–100% of the time
across the different scenarios.
Imposed clustering in the control arm
Methods for imposing clustering in the control arm, pre-
sented in Table 3, had a negligible impact on the per-
formance measures of the partially nested mixed-effects
models (models 3 and 4). Under the simulation scenar-
ios, the differences in the p-value, confidence intervals
Fig. 1 Flowchart representing the simulation study steps
Table 4 Simulation input scenario values (total 1440 scenarios)
Variable Notation Values
Number of clusters c 3, 6, 12, 24
Cluster size m 5, 10, 20, 30
Intervention effect θ 0, 0.2, 0.5
ICC ρ 0, 0.01, 0.05, 0.1, 0.2a, 0.3a
Ratio of individual variance
between control and cluster
trial arms
γ 0.25a, 0.5, 1, 2, 4a
aConsidered extreme values to occur in rare scenarios
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and estimated ICC between the methods were only
present at four decimal places. Model fitting was consid-
erably faster (around four to five times faster) using ei-
ther one large cluster or the pseudo clusters compared
to the singleton clusters, however, this will likely be im-
material when fitting only a small number of models.
Methods for imposing clustering in the control arm
had a large impact on the performance measures of the
fully clustered mixed-effects models (models 2.1, 2.2,
and 2.3). Specific results for each performance measure
are presented in the following sections.
Results are reported only for the partially nested
mixed-effects models (models 3 and 4) with the
non-clustered controls classified as one large cluster, as
other methods were comparable. All three methods for
classifying the non-clustered control arms for the fully
clustered mixed-effects model (models 2.1, 2.2, and 2.3)
are reported.
Bias
The bias of the intervention effect estimate was not af-
fected by the analysis model used, individual variances
(γ) or the ICC (ρ). The maximum absolute bias of the
intervention effect was |0.057|, |0.043|, and |0.053| for
θ = 0, 0.2 and 0.5, respectively.
Mean square error
The models produced unbiased estimators with no dif-
ference in the observed MSE between the different
models. The MSE of the intervention effect estimate had
a mean of 0.051 (standard deviation (SD) 0.056) and
maximum of 0.346.
Type I error
Plots of the mean Type I error rates split by model, the
ratio of individual variances (γ) and the ICC (ρ) are pre-
sented in Fig. 3. As would be expected the linear regres-
sion model which ignores clustering had inflated Type I
error rates, with Type I error rate affected by ICC (ρ),
the ratio of individual variances (γ), number of clusters
(c), and cluster size (m). Although the inflation was
minimal when ICC ρ = 0.01, the mean Type I error
was 0.061 (SD 0.010). When cluster size m ≤ 10 and
ICC ρ = 0.01 the mean Type I error rate was 0.056
(SD 0.007).
Model 2, the fully clustered models with imposed clus-
tering in the control arm resulted in biased Type I error
rates. Imposing clustering as singleton clusters (model
2.1) led to Type I error rates which were largely affected
by the ratio of individual variances (γ) and ICC (ρ). Im-
posing one large cluster in the control arm (model 2.2)
resulted in Type I error rates of zero (due to the
Satterthwaite degrees of freedom correction resulting in
large degrees of freedom when imposing one large clus-
ter in the control arm). Imposing pseudo clusters in the
control arm of the same size as the intervention arm
(model 2.3) provided relatively good control of Type I
error rates, mean Type I error of 0.039 (SD 0.018), but
was affected slightly by both the ratio of individual
variances (γ) and ICC (ρ).
Both the homoscedastic and heteroscedastic partially
nested models (models 3 and 4) provided good control of
Type I error rates (model 3: mean Type I error 0.045 (SD
0.016) and model 4: mean Type I error 0.044 (SD 0.014))
with little difference present between the two models.
For more detailed comparison Fig. 4 presents the Type
I error rates for the linear regression model (model 1),
the homoscedastic (model 3) and the heteroscedastic
(model 4) partially nested models by ICC (ρ), the ratio
of individual variances (γ), number of clusters (c), and
cluster size (m). Higher ICC values resulted in higher
Type I error rates in each model. The impact of ignoring
clustering (model 1) depends on both ICC (ρ), cluster
size (m), and number of clusters (c). Larger number of
clusters (c) resulted in better control of Type I error
rates for the partially nested models. When ICC ρ = 0,
the Type I error rates of the partially nested models
(models 3 and 4) were reduced from the nominal level.
This is due to the cluster variance components being es-
timated when they are not actually present in the data.
When the ICC was small (ρ ≤ 0.05) and the individual
variance in the control arm smaller than that in the
intervention arm (γ < 1), the Type I error rates of par-
tially nested models were reduced from the nominal 5%
level. When ICC was large (ρ = 0.3) the partially nested
models generally resulted in inflated Type I error rates.
As ICC increased Type I error rates increased, with the
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Fig. 2 Example of simulated partially nested trial dataset, ρ = 0.1,
γ = 1, c = 12, and m = 10
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partially nested models 3 and 4 only reaching above the
nominal Type I error rate of 5% on average when ICC
ρ ≥ 0.2.
The Satterthwaite correction used in Stata mixed
(dfmethod(sat)) did not fully correct the Type I error
rates to the nominal 5% level, even with the use of the
heteroscedastic model 4. The heteroscedastic model 4
did have slightly improved control of Type I error rates
than the homoscedastic model 3.
Coverage
Plots of the mean coverage of the 95% confidence inter-
vals of the intervention effect estimate split by model,
ICC (ρ) and the ratio of individual variances (γ) are pre-
sented in Fig. 5 under the alterative hypothesis. The lin-
ear regression model (model 1) resulted in under
coverage when ICC was small (ρ ≤ 0.05) and the cover-
age rates decrease as ICC (ρ) increases. The fully clus-
tered models with imposed clustering in the control arm
resulted in both over and under coverage dependent on
the direction of the variance ratio and the method of im-
posed clustering. Imposing clustering as singleton clus-
ters (model 2.1) resulted in coverage rates largely
affected by ratio of individual variances (γ). Imposing
one large cluster in the control arm (model 2.2) resulted
in over coverage, due to the reduced Type I error rates
of zero caused by the Satterthwaite degrees of freedom
correction. Imposing pseudo clusters in the control arm
(model 2.3) provided mean coverage rates of 0.961 (SD
0.018).
Both the homoscedastic and heteroscedastic partially
nested models (models 3 and 4) provided good control
of coverage rates of 95% confidence intervals (model 3:
mean coverage rate 0.956 (SD 0.014) and model 4: mean
coverage rate 0.956 (SD 0.014)) with little difference be-
tween the two models. In the simulations over coverage
of the 95% confidence intervals for the heteroscedastic
model 4 occurred when ICC ρ ≤ 0.05, except when the
Fig. 3 Mean Type I error rate by γ and ρ over all scenarios, for each model
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ratio of individual variances γ = 4. Hence, the results
were generally conservative when ICC was small. Under
coverage of the 95% confidence intervals for the hetero-
scedastic model 4 only occurred for large ICC (ρ) and
ratio of individual variances (γ).
Power
Increasing the number of clusters as opposed to increas-
ing the cluster size had a bigger impact on power with a
fixed total sample size. Fig. 6 shows the power of the lin-
ear regression model (model 1), the homoscedastic
(model 3) and the heteroscedastic (model 4) partially
nested models when intervention effect θ = 0.5 by ICC
(ρ), the ratio of individual variances (γ), number of
clusters (c), and cluster size (m) (see Additional file 2 for
when θ = 0.2). Under the simulation scenarios con-
ducted, 12 or more clusters and cluster sizes of ten or
more were generally needed for a power greater than
80%. Using three or six clusters rarely gave power over
80%, only for ICC ρ ≤ 0.05 and relatively large cluster
sizes m ≥ 20, did power go over 80%.
For ICC ρ ≤ 0.05, which is commonly assumed when
planning complex intervention trials in healthcare,
power of 80% was generally achieved with: 24 clusters of
any size, 12 clusters of size ten or more, and six clusters
of size 20 or more (120 in each arm).
Under a ratio of individual variances γ = 1 the total
residual variance in both trial arms is equal to one,
hence, the intervention effect (θ) we simulated is the
standardised intervention effect. Figure 7 shows the
power of models 1, 3 and 4 under homoscedastic indi-
vidual variances (γ = 1). The heteroscedastic model 4 is
over-parameterised in the case of the ratio of individual
variances γ = 1, however, it did not result in a substan-
tially lower power than the homoscedastic model.
Table 5 presents the power of model 4 and model 1
under ICC ρ = 0, model 4 is over-parametrised here.
There is a loss in mean statistical power which ranged
between 1.7 to 6.3%.
ICC
Figure 8 presents the mean estimated ICC across the
fully clustered and partially nested mixed effect models,
Fig. 4 Type I error rate of models 1, 3 and 4, by ρ, γ, c, and m
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by the ratio of individual variances (γ) and ICC (ρ). ICC
estimation was consistent under the heteroscedastic par-
tially nested model (model 4). The homoscedastic par-
tially nested model (model 3) resulted in biased ICC,
with the direction of bias dependent upon the ratio of
individual variances (γ).
Figure 9 presents the ICC for the homoscedastic
(model 3) and heteroscedastic (model 4) partially nested
models by the ratio of individual variances (γ), ICC (ρ),
number of clusters (c), and cluster size (m). The ICC es-
timation from the homoscedastic model was highly af-
fected by γ. The ICC estimation from the
heteroscedastic model was not affected by γ. Using the
heteroscedastic model, there was a slight positive bias in
the ICC estimation when ICC ρ ≤ 0.05, and when ICC
ρ ≥ 0.2 there was slight negative bias in the ICC estima-
tion. For example, when ICC ρ = 0.0 the mean ICC esti-
mation was 0.028 (SD 0.018), and when ICC ρ = 0.05 the
mean estimation was 0.060 (SD 0.014). As expected ICC
estimation improved as sample size increased. The ICC
estimation was only consistent across all values of ICC
(ρ) when there were 24 clusters, regardless of cluster
size. For an accurate estimate of ICC when true ICC ρ =
0.05, under the simulation scenarios we required cluster
sizes (m) of 20 or 30 or at least six clusters of size ten or
24 clusters of size five.
Summary of results
Simulation results are summarised in Table 6 presenting
the performance of the simple linear regression model
(model 1), homoscedastic partially nested mixed effects
model (model 3) and heteroscedastic partially nested
mixed effects model (model 4) under different design
scenarios. Results from the fully clustered mixed-effects
models (model 2) are excluded from Table 6 as we do
not recommend these in any scenario regardless of the
method used to impose clustering in the control arm.
None of the fully clustered mixed-effects models pro-
vided full control of the Type I error rates and the par-
tially nested mixed effects models always outperformed
them.
Discussion
In this study, we have investigated six modelling strat-
egies for the analysis of pnRCTs with a continuous out-
come. Our simulation study showed that when analysing
pnRCTs the use of the heteroscedastic partially nested
mixed-effects model for normally distributed outcome
Fig. 5 Mean coverage of 95% confidence interval, by ρ and γ over all scenarios
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Fig. 6 Power when θ = 0.5, by ρ, γ, c, and m
Fig. 7 Power with standardised intervention effect of 0.5 (θ = 0.5 and γ = 1)
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data (using Satterthwaite degrees of freedom) in general
provides: unbiased effect estimates; maintains relatively
good control of Type I error rates; and did not noticeably
cause a reduction in power even with homoscedastic indi-
vidual variances across arms. The heteroscedastic partially
nested model takes account of the between-cluster
variance (if present) and therefore provides valid infer-
ences for the intervention effect. Additional file 2 presents
model-fitting code for R, Stata and SAS. When using the
partially nested mixed-effects model, the method of classi-
fying the non-clustered controls had a negligible impact
on statistical inference under the simulation scenarios,
agreeing with findings from analysis of four example
pnRCTs by Flight et al. [9].
Our findings were broadly similar to those of Bald-
win et al. [15]. However, they did not assess the
method of classifying the non-clustered controls or
performance of models under small ICC (ρ = 0.01,
lowest value used in our study) which commonly
occur in pnRCTs [7–9, 26, 29]. Unlike findings from
Baldwin et al. [15], the Satterthwaite degrees of freedom
correction did not fully control the Type I error rate in
our simulations. The largest discrepancy from the nominal
level occurred when the ICC was small, ratio of individual
variances <1, and under small sample sizes.
Table 5 Mean and SD of power of model 4 versus model 1
under ρ = 0 over all scenarios
Intervention
effect (θ)
Model Power
Mean (SD)
0 1 0.050 (0.007)
4 0.033 (0.014)
0.2 1 0.388 (0.276)
4 0.327 (0.286)
0.5 1 0.803 (0.254)
4 0.740 (0.298)
Fig. 8 Mean estimated ICC by γ and ρ over all scenarios, for each model
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We have illustrated that using a naïve linear regression
model, which ignores clustering in pnRCTs, gave inflated
Type I error rates and resulted in under coverage of
confidence intervals when clustering of outcomes was
present. When ICC 0.01 ≤ ρ ≤ 0.05, which we believe is
common in pnRCTs [9], ignoring clustering led to
largely inflated Type I error rates using the linear regres-
sion model. A low ICC may still have a large impact,
particularly when cluster sizes are large.
When ICC was small and/or with very few clusters
and small cluster sizes using the partially nested
mixed-effects models 3 and 4 resulted in underestimated
Type I error rates. These models correctly reflect the de-
sign of the trials; however, they can result in conservati-
vism regarding the precision of estimates due to the bias
in estimating the variance estimates when we have a
small number of clusters. Consequently, using the par-
tially nested mixed effects models with small ICC may
make it difficult to detect differences between the trial
arms when present.
Sanders [17] recommend evaluating whether ICC is sig-
nificantly different from zero prior to selecting an analysis
method. We caution such significance testing for ICC,
and similarly testing for heteroscedasticity [7]. These tests
will generally lack power in a pnRCT and it is not the
statistical significance of the ICC that matters but impact
of the magnitude on inference. In general, we recommend
the use of the partially nested models when analysing
pnRCT trials, particularly if conservatism and an ICC esti-
mate are desired. However, the choice of model and the
requirement or not for conservatism needs to be consi-
dered in the context of the specific trial setting.
Similar to cRCTs [1], in a pnRCT increasing the number
of clusters rather than increasing the cluster size has a
greater increase in power for a fixed total sample size. Our
simulation results showed that this will also provide a more
accurate estimation of the ICC. When the number of clus-
ters is small, for example, three clusters in the intervention
arm, the ICC estimation will likely be upwardly biased.
With six clusters in the intervention arm, the ICC estimate
was relatively unbiased once the true ICC ≥0.1. The ICC
estimation became consistent regardless of cluster size or
true ICC only once there were 24 clusters in the simulation
scenarios. This reflects findings from previous research that
to reliably estimate the size of clustering effects a large
number of clusters are required [30].
This study investigated the case of analysing partially
nested trials under complete compliance. Non-compliance
in the clustered arm of a pnRCT may occur when some
participants randomised to a particular treatment group or
Fig. 9 ICC estimation of heteroscedastic partially nested model, by γ, ρ, m and c
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care provider do not attend any sessions or receive treat-
ment as part of different treatment group or care provider
intended at randomisation. Consequently, non-complier
outcomes may be assumed independent if they do not
receive the clustered intervention. Schweig and Pane [16]
describe and compare models for pnRCTs with non-com-
pliance using a simulation study. They argue that an un-
biased intention-to-treat (ITT) estimate under non-
compliance on a pnRCT may be obtained using a Complier
Average Causal Effects (CACE) model. This method in-
volves estimating the treatment effect for compliers and
scaling this CACE effect estimate by the proportion of
compliers to provide an ITT effect estimate. The issues
posed by non-compliance warrant further investigation,
considering a broader range of scenarios and investigating
the degrees of freedom corrections for valid statistical
inferences.
The design and analysis of trials with clustering in one
arm needs to take account of heterogeneity and ICC to
have a sufficiently powered sample size and accurate
intervention effect. We strongly recommend the reporting
of ICCs in trials results papers. The framework developed
for cRCTs is also broadly applicable in iRCTs with cluster-
ing, identifying three dimensions to consider when report-
ing an ICC: a description of the dataset (including
characteristics of the outcome and the intervention); how
the ICC was calculated; and the precision of the ICC [31].
This has the potential to improve the assumptions about
ICCs in iRCTs, adhere to CONSORT reporting guidelines
for RCTs of nonpharmacological interventions [32], and
raise awareness of the need to account for clustering in
both the sample size and analysis in iRCTs with clustering.
A wide variety of terminology are used in iRCTs with
clustering in one arm, including partially nested, partially
clustered, multi-level, and individually randomized group
intervention. A more consistent use of terminology would
reduce confusion, improve reporting and make finding
relevant ICCs from previous trials easier. We suggest the
terminology partially nested randomised trial (pnRCT) to
describe an iRCT with clustering in one arm.
Limitations
All the mixed-effects models assume that the cluster
level means follow a Normal distribution. This may not
be a valid assumption, for example, when we have a
small number of clusters.
In the simulations, we have used fixed cluster sizes. In
practice, cluster size may vary, causing a loss in efficiency
when estimating the intervention effect. A simulation
study by Candel and Van Breukelen [10] found the effi-
ciency loss in the intervention effect estimate was rarely
more than 10%, requiring recruitment of 11% more
Table 6 Summary of simulation results by different models split by ρ, m, and c averaged over all γ
*Model 1: simple linear regression; Model 3: homoscedastic partially nested mixed effects model; Model 4: heteroscedastic partially nested mixed effects model.
Green highlighted ≤ than expected, red highlighted > than expected
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clusters for the intervention arm and 11% more individ-
uals for the control arm. The loss of efficiency in the inter-
cept variance reached to 15%, requiring 19% more clusters
in the clustered arm, and no additional recruitment in the
control arm. Additionally, it has been shown in cluster tri-
als if the coefficient of variation in cluster size is small, less
than 0.23, then the correction on sample size is negligible
[33]. It should be noted that cluster sizes are likely to be
more similar in group administered interventions com-
pared to trials which impose clustering by being treated
by the same care provider [7].
Throughout the simulations we assumed there was no
effect of clustering in the control arm, this may not strictly
be true in practice. In healthcare intervention trials, a
commonly used control intervention is ‘care as usual’. This
type of control may induce some form of low-level clus-
tering, for instance, treatment by a healthcare practitioner.
If the same practitioner treats numerous individuals, we
can assume, in the same sense as we have done for the
intervention arm that these individuals are clustered and
include this in the modelling procedure. However, this in-
formation is often not available in trial data and is not
unique to pnRCTs.
Partially nested trials pose a number of challenges, in
particular, the issue of internal validity [6]. The grouping
of individuals as part of the delivery of a treatment may
affect the outcome. However, taking a pragmatic view-
point, we consider the grouping as part of the treatment
as a whole if this is reflective of treatment delivery in
real-world practice. In addition, if the ungrouped con-
trols are the true comparison in real life a pnRCT design
will provide external validity.
Conclusion
Partially nested RCTs are increasingly used in complex
intervention research. Ignoring clustering can lead to infla-
tions of the Type I error rates, even for small ICCs. When
analysing a pnRCT with continuous outcomes we recom-
mend the use of a heteroscedastic partially nested
mixed-effects model with corrected degrees of freedoms
such as using the Satterhwaite method, for outcomes similar
to those generated under the scenarios of our simulations
study. The method used for classifying the non-clustered
controls had a negligible impact on the results using the par-
tially nested mixed-effects model. The model is easy to im-
plement in standard statistical software and does not cause a
notable reduction in power under homoscedastic variances.
With few clusters, small cluster sizes and small ICC, the par-
tially nested model underestimated Type I error rates and
gave largely inflated ICC estimates, hence, for such designs
there is no optimal model and we need to be cautious in
model interpretation. Finally, to aid the design and prior
selection of an appropriate analysis plan for pnRCTs, we
strongly recommend the reporting of estimated ICC when
publishing trials results.
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